本页面由Tiger Trade Technology Pte. Ltd.提供服务

和黄医药

13.61
-0.4950-3.51%
成交量:2.79万
成交额:38.43万
市值:23.73亿
市盈率:134.77
高:14.00
开:14.00
低:13.58
收:14.10
52周最高:16.33
52周最低:9.77
股本:1.74亿
流通股本:1.04亿
量比:0.69
换手率:0.03%
股息:- -
股息率:- -
每股收益(TTM):0.1010
每股收益(LYR):2.60
净资产收益率:1.46%
总资产收益率:-1.24%
市净率:1.88
市盈率(LYR):5.23

数据加载中...

2020/11/27

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/07/30

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/07/07

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/07/06

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/04/29

[修订]年度报告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/03

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/03

财报披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/21

SEC问询函

CORRESP [Cover] - Correspondence
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/29

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/01/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/22

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]